Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTHERA PHARMACEUTICALS INC

 SummaryNewsCompany 
Company
Anthera Pharmaceuticals, Inc. (Anthera) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases. The Company has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement... 
More about the company
All news about ANTHERA PHARMACEUTICALS INC
2017ANTHERA PHARMACEUTICALS INC : REVERSE SPLIT: 1 of 8
FA
2017Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock
GL
2017Anthera Announces Completion of Dosing in the Phase 2 BRIGHT-SC Study of Blis..
GL
2017DEADLINE ALERT : Brower Piven Reminds Investors Of The Upcoming Deadline In Clas..
BU
2017Anthera Announces Positive Results from the Extension Period of the SOLUTION ..
GL
2017ANTH The Law Offices of Vincent Wong Reminds Investors of a Class Action Invo..
BU
2017Anthera Pharmaceuticals Announces Pricing of $15.0 Million Public Offering of..
GL
2017Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock an..
GL
2017Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 Fr..
BU
2017ANTHERA PHARMACEUTICALS  : Provides Business Update and Reports 2016 Fourth Quar..
PU
2017Anthera Pharmaceuticals Provides Business Update and Reports 2016 Fourth Qua..
GL
2017ROBBINS ARROYO LLP : Anthera Pharmaceuticals, Inc. (ANTH) Misled Shareholders Ac..
BU
2017Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Anthera Pharmac..
PR
2017Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violatio..
BU
2016ANTHERA PHARMACEUTICALS  : Announces the Phase 3 SOLUTION Study with Sollpura&tr..
PU
More news
News in other languages on ANTHERA PHARMACEUTICALS INC
2016Wall Street termine dans le rouge, le rally s'essouffle
More news
Managers and Directors
NameTitle
David E. Thompson Independent Director
Brent Furse Independent Director
Bradley A. Bugdanowitz Secretary
Sector and Competitors
1st jan.Capitalization (M$)
ANTHERA PHARMACEUTICALS INC2
GILEAD SCIENCES, INC.12.67%83 740
WUXI APPTEC CO., LTD.17.84%59 429
VERTEX PHARMACEUTICALS-9.51%55 364
REGENERON PHARMACEUTICALS0.43%49 948
BIONTECH SE109.48%41 245